Rigel Pharmaceuticals



Ebitda Veränderung Datum
Amgen USD 3.75B 42M 2025-03
Arrowhead Research USD 397.34M 553.52M 2025-03
AstraZeneca USD 5.08B 182M 2025-03
BioMarin Pharmaceutical USD 245.96M 51.11M 2025-03
Bristol-Myers Squibb USD 4.9B 16M 2025-03
Celldex Therapeutics USD -61872000 6.66M 2025-03
Daiichi Sankyo JPY 101.6B 22.81B 2025-03
Eli Lilly USD 4.16B 2B 2025-03
Halozyme Therapeutics USD 162M 33.97M 2025-03
Ionis Pharmaceuticals USD -141463000 35.91M 2025-03
Ligand Pharmaceuticals USD 10.33M 9.62M 2024-12
MacroGenics USD -50784000 106.81M 2024-12
Neurocrine Biosciences USD 152.1M 39.2M 2024-12
Pfizer USD 6.21B 1.5B 2025-03
Regeneron Pharmaceuticals USD 730.9M 324.8M 2025-03
Ultragenyx Pharmaceutical USD -113199000 10.03M 2024-12
Veracyte USD 13.18M 4.9M 2024-12



Rigel Pharmaceuticals - Diese Werte, historische Daten, Prognosen, Statistiken, Diagramme und ökonomische Kalender - May 2025.